Duloxetine
Product Images NDC 55700-605

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 55700-605). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quality Care Products Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (New Doc 2018 04 18 1)

This is a box of Duloxetine DR 30mg capsules. The recommended storage temperature is between 53-86 degrees F. It is important to keep this medication out of reach of children. The box contains 30 capsules, and the GTIN number is 00355700605308. The NDC number is 55700-0605-30. The manufacturer is Ajanta Pharma Limited, located in Paithan 431 148, India. There is a warning to consult with a physician or see an insert for dosage information. The text also includes a serial number, lot number, and expiration date, but they are not legible due to the quality of the .*

FDA Label Image

Figure01 (Duloxetine Fig01)

This is a graph showing the proportion of patients with relapse for a certain treatment (placebo or duloxetine) over time (measured in days). The X-axis shows the time from randomization to relapse while the Y-axis shows the proportion of patients with relapse. The graph indicates that the treatment with duloxetine was associated with fewer relapses compared to placebo.*

FDA Label Image

Figure2 (Duloxetine Fig02)

The text represents a graph that shows the proportion of patients with relapse over time after treatment with a placebo or duloxetine. The x-axis represents the time from randomization to relapse in days, while the y-axis shows the proportion of patients. The graph indicates that fewer patients relapsed with duloxetine compared to the placebo, suggesting that duloxetine may be an effective treatment for preventing relapse.*

FDA Label Image

Figure04 (Duloxetine Fig04)

FDA Label Image

Figure07 (Duloxetine Fig07)

This text appears to be a chart or graph displaying the effectiveness of the drug Placebo in comparison to Duloxetine at doses of 60/120 mg taken once daily. It appears to show the percentage improvement in pain from baseline using a BOCF measurement. The meaning of the symbols (letters, numbers, and shapes) in the graph is not clear, so no additional information can be provided.*

FDA Label Image

Figure08 (Duloxetine Fig08)

This appears to be a graph displaying the percent improvement in pain from baseline (BOCF) between a placebo and the drug Duloxetine (at a 60 mg daily dose). The numbers on the x-axis appear to represent different time intervals. There is no further information available to determine the context of the study or the purpose of the graph.*

FDA Label Image

Figure09 (Duloxetine Fig09)

The text describes the use of Duloxetine at a dose of 60-120mg once daily for the treatment of pain. It also includes a chart showing the percent improvement in pain from baseline.*

FDA Label Image

Duloxetine-structure (Duloxetine Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.